Nimblique Studio

Nimblique Studio is the commercial identity of developer Hemang Vyas. Its privacy notice describes an individual freelance practice. The studio builds custom applications, online shops and business tools. It also owns the Movelira, Zentra Foundry and LiveOps Goblin projects.

Zentra Foundry is its data-product brand. The Apify publisher uses Zentra and the account name zentrafoundry, with a Nimblique-Studio label. The separate Zentra Foundry website offers datasets and reference packs. Marketplace products and website packs do not establish shared purchase entitlements.

The listed pharmaceutical product is FDA Drug Enforcement Monitor. It retrieves US openFDA drug-enforcement records for internal quality and competitor review. Wider pharmacovigilance functionality and named pharmaceutical customer references are unverified.

The studio is a general software practice with a specific pharmaceutical recall-data offer. FDA Drug Enforcement Monitor targets internal pharmaceutical quality and competitor monitoring. Adverse-event processing and safety-signal detection are unverified. Named pharmaceutical customers, regulated deployments and inspection outcomes are also unverified.

Revenue, funding, profitability, ownership finance and acquisition history are unverified. Studio service-package prices do not establish the monitoring product price or implementation cost.

The studio identifies Movelira, Zentra Foundry and LiveOps Goblin as owned projects. Zentra includes data products and Apify Actors. Only FDA Drug Enforcement Monitor is listed here. The studio says its own projects are not client engagements or proof of sales performance.

The requested monitoring product runs on Apify. This marketplace presence does not establish certified partner status, pharmaceutical system connectors or inherited security attestations. Product-specific integration partners are unverified.

The studio offers a direct development relationship for defined custom projects. The monitoring Actor's support hours, service levels, training, validation services, incident escalation and backup maintainers are unverified.

The studio publicly names Hemang Vyas as its developer. Company certificates, product-scoped attestations, analyst recognition and pharmaceutical regulatory credentials are unverified. The studio website privacy notice covers site visits and inquiries, not the Actor's security or validation.

Public presence includes the studio website, the Zentra Foundry website and the Zentra Apify publisher account. The current drug-monitoring name differs from the retained FDA Safety Signal Monitor v2 URL. Pharmaceutical conference activity and market share are unverified.